Bedford, MA, United States of America

John Niu

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Tetraphase Pharmaceuticals, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Niu. Retrieved from https://idiyas.com/inventor/john-niu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of John Niu in Pharmaceutical Chemistry

Introduction

John Niu is a notable inventor based in Bedford, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline forms of eravacycline. With a total of 3 patents to his name, Niu's work has the potential to impact the treatment of various disorders.

Latest Patents

Niu's latest patents focus on the crystalline forms of the bis-HCl salt of a compound represented by Structural Formula 1. These inventions include pharmaceutical compositions that incorporate these crystalline forms, specifically crystalline Form I, crystalline Form J, crystalline Form A, and crystalline Form B. The methods for preparing these crystalline forms are also described, highlighting their importance in creating effective pharmaceutical compositions.

Career Highlights

John Niu is currently associated with Tetraphase Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is crucial in advancing the development of new treatments that can address various health issues.

Collaborations

Niu collaborates with talented individuals such as Danny LaFrance and Philip C Hogan, contributing to a dynamic research environment that fosters innovation.

Conclusion

John Niu's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His work on crystalline forms of eravacycline is a testament to the potential of innovative research in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…